Huiqin Chen Selected Research

Huiqin Chen Research Topics

Disease

40	Neoplasms (Cancer) 04/2024 - 09/2010
20	Breast Neoplasms (Breast Cancer) 11/2023 - 12/2009
5	Triple Negative Breast Neoplasms 01/2024 - 10/2011
4	Neoplasm Metastasis (Metastasis) 11/2020 - 06/2011
3	Lung Neoplasms (Lung Cancer) 04/2023 - 09/2018
3	Inflammation (Inflammations) 01/2023 - 08/2021
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 02/2024
2	Carcinogenesis 04/2024 - 11/2020
2	Fibrosis (Cirrhosis) 04/2023 - 11/2020
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 01/2018
2	Adenoma (Adenomas) 01/2023 - 01/2022
2	Pathologic Complete Response 01/2023 - 09/2010
2	Melanoma (Melanoma, Malignant) 11/2020 - 01/2019
2	Cardiomegaly (Heart Hypertrophy) 04/2020 - 12/2019
2	Infections 08/2017 - 01/2008
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2015 - 03/2012
2	Residual Neoplasm 02/2012 - 12/2009
1	Myocardial Infarction 03/2024
1	Hypoxia (Hypoxemia) 03/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2024
1	Carcinoma (Carcinomatosis) 02/2024
1	Dyskinesias (Dyskinesia) 07/2023
1	Parkinson Disease (Parkinson's Disease) 07/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Epstein-Barr Virus Infections 01/2022
1	Adenocarcinoma 01/2022
1	Wounds and Injuries (Trauma) 08/2021
1	Stroke (Strokes) 01/2021
1	Hemiplegia (Spastic Hemiplegia) 01/2021
1	Convalescence 01/2021
1	Lung Injury 11/2020
1	Cutaneous Malignant Melanoma 10/2020

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2012
8	Hormones (Hormone)IBA 01/2018 - 06/2011
6	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2012
5	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2010
4	Sirolimus (Rapamycin)FDA Link 08/2015 - 10/2010
3	Estrogen ReceptorsIBA 01/2019 - 06/2011
3	MK 2206IBA 01/2019 - 10/2012
3	Estrogens (Estrogen)FDA Link 06/2017 - 01/2013
2	Phenobarbital (Luminal)FDA Link 04/2024 - 02/2024
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 11/2023 - 11/2023
2	RadonIBA 04/2023 - 11/2020
2	ParaffinIBA 01/2021 - 01/2013
2	Formaldehyde (Formol)FDA Link 01/2021 - 01/2013
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 12/2019 - 02/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2018 - 10/2014
2	Phosphotransferases (Kinase)IBA 11/2018 - 10/2014
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2008
2	MTOR InhibitorsIBA 06/2015 - 03/2012
2	Octreotide (Sandostatin)FDA LinkGeneric 06/2015 - 03/2012
2	Everolimus FDA Link 06/2015 - 03/2012
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2013 - 06/2011
2	Stearoyl-CoA DesaturaseIBA 01/2013 - 10/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 06/2011
2	Small Interfering RNA (siRNA)IBA 10/2012 - 10/2010
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2012 - 10/2010
2	Trastuzumab (Herceptin)FDA Link 10/2011 - 12/2009
2	taxaneIBA 09/2010 - 12/2009
2	AnthracyclinesIBA 09/2010 - 12/2009
1	Circular RNAIBA 03/2024
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 03/2024
1	futibatinibIBA 11/2023
1	Cell-Free Nucleic AcidsIBA 11/2023
1	osimertinibIBA 11/2023
1	Levodopa (L Dopa)FDA LinkGeneric 07/2023
1	Cisplatin (Platino)FDA LinkGeneric 03/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	Toll-Like Receptor 4IBA 01/2023
1	ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA 01/2023
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2023
1	InterleukinsIBA 07/2022
1	RG7388IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	AZD 6244IBA 01/2022
1	ChromatinIBA 01/2022
1	histone H3 trimethyl Lys4IBA 01/2022
1	Histones (Histone)IBA 01/2022
1	HeterochromatinIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	mouse propeptide convertase 5IBA 08/2021
1	Streptozocin (Streptozotocin)FDA Link 08/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2020
1	AfatinibIBA 10/2020
1	CrizotinibIBA 10/2020
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 10/2020
1	Insulin (Novolin)FDA Link 10/2020
1	Antisense RNA (Anti-Sense RNA)IBA 04/2020

Therapy/Procedure

20	Therapeutics 04/2024 - 12/2009
9	Neoadjuvant Therapy 01/2024 - 12/2009
4	Drug Therapy (Chemotherapy) 01/2018 - 09/2010
2	Aftercare (After-Treatment) 11/2023 - 01/2020
1	Combination Drug Therapy (Combination Chemotherapy) 03/2024
1	Oral Administration 01/2023